Sun Pharmaceutical Industries Ltd, the largest Indian drug manufacturer, has acquired 14 prescription brands from Novartis AG and Novartis Pharma AG in Japan for $293 million, the company said on Tuesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
